In the debate over government control of health care in the United States, critics looked at the UK system and its death panels, which drew an arbitrary line on when to stop treatment. Their recent efforts led to such an outcry that the government has said they were ending the incorrectly named Liverpool Care Pathway and its policy of subtle euthanasia.

Most ethicists in the UK have been in favor of letting government rather than doctors determine patient care but an Emeritus Professor of medical ethics at Imperial College London talking at this year's Euroanaesthesia meeting titled will at least argue that a patient's age should not in itself be considered an ethically relevant criterion for deciding 'where to stop' treatment.

While western nations have dropped emissions on schedule, led by the United States, which has pushed its greenhouse gas emissions from energy back to early 1990s levels and coal back to early 1980s levels, the increasingly modern developing world have continued to produce more emissions, causing worldwide levels to rise.

There is no short cut. Emissions need to be reduced. So forget about positioning giant mirrors in space to reduce the amount of sunlight being trapped in the earth's atmosphere or seeding clouds to reduce the amount of light entering earth's atmosphere - if we can't figure out why emissions have risen but temperatures have not, tinkering with clouds is a very bad idea.

There is good news for cancer survivors - their numbers continue to grow.

There are currently 14.5 million cancer survivors in the USA and that will grow to almost 19 million by 2024, according to the second edition of Cancer Treatment&Survivorship Facts & Figures, 2014-2015 and an accompanying journal article published in CA: A Cancer Journal for Clinicians.

Cancer rates have been decreasing for 10 years and the number of cancer survivors is growing, even with an aging population. This is due primarily to earlier cancer detection and more effective treatments.

As targeted therapies become more available, increasing opportunity exists to match treatments to the genetics of a specific cancer - but oncologists have to know these genetics in order to make the match, which requires molecular testing of patient samples.

As government increasingly takes control of health care, the standard for such non-essential  tests is going to be set far higher for poor people but there were still be more of them, so oncologists are going to have to make sure that patients' samples are properly tested, helping to pair patients with the best possible treatments. 

Everything you do changes your brain, even reading this sentence. A psychologist from the University of Hertfordshire believes that clothing impacts the way we think and literally changes our brains.

We know some of this to be true; everyone has a favorite outfit they look good in and that makes them feel more confident.  Professor Pine's data consists of things like asking psycology students to put on a Superman t-shirt. They declared it made them have better impressions of themselves and that they felt physically stronger. To most people, that says psychology undergraduates are as mentally developed as four-year-olds but to Pine it became a book, Mind What You Wear: The Psychology of Fashion.

In Mexico, 21.7 percent of the population smokes. By now, smoking has been implicated in every possible condition - lung cancer, obviously, but then crazy claims like that third-hand smoke could lead to epigenetic changes that make your grandchildren obese.

New Haven, Conn. — A multi-center phase I study using an investigational drug for advanced bladder cancer patients who did not respond to other treatments has shown promising results in patients with certain tumor types, researchers report. Yale Cancer Center played a key role in the study, the results of which will be presented Saturday, May 31 at the 2014 annual conference of the American Society of Clinical Oncology (ASCO) in Chicago.

Structural biologists have made important progress towards better understanding the functioning of the circadian clock. The circadian or inner clock coordinates the sleep-wake rhythm and many other body processes that regulate, for example, metabolism, blood pressure, and the immune system. A research team led by Professor Eva Wolf, recently appointed Professor of Structural Biology at the Institute of General Botany of Johannes Gutenberg University Mainz (JGU) and Adjunct Director at the Institute of Molecular Biology (IMB), has for the first time identified the molecular structure of a protein complex that plays an important role in regulating the circadian rhythm.

The clinical promise of stem cells has been dampened by concerns that the immune system will reject the transplanted cells before they could render any long-term benefit.

Previous research in mice has suggested that even adult stem cells produced from a subject's own tissue, induced pluripotent stem (iPS) cells, can trigger an immune attack.

Now researchers at the Stanford University School of Medicine have found that differentiating iPS cells in the laboratory to become more-specialized progeny cells before transplantation into mice allows them to be tolerated by the body's immune system.

CHICAGO – People in the late stages of cancer and other terminal illnesses are not only unharmed by discontinuing statins for cholesterol management, they may benefit, according to a study presented Friday by researchers at Duke Medicine representing a national research network.

The finding addresses a thorny question in treating people with life-limiting illnesses: When, if ever, is it appropriate to discontinue medications prescribed for other conditions that will likely not lead to their death?